AI-driven scams impersonating European health authorities are rapidly increasing across Europe as fake Ozempic and other GLP-1 products spread through highly convincing fraudulent ads. This trend creates serious risks for consumers and for authorities working to protect the public from dangerous medicine scams.
Check Point Software warns of a surge in sophisticated adverts that mimic official communications from European health agencies to sell counterfeit weight-loss drugs. Criminal networks are using generative AI to produce adverts, written endorsements, expert quotes and graphical assets that closely resemble authentic materials from real agencies. The result is advertising that many users perceive as official and trustworthy.
Demand for GLP-1 medicines such as Ozempic and Mounjaro in 2025 has created a lucrative market that cybercriminals exploit by rapidly launching counterfeit alternatives. These fake products are often sold at high prices and marketed as approved or genuine, even though they contain no verified active ingredients or proper quality control.
AI used to impersonate authorities and build credibility
Scammers copy visual and textual elements from well-known agencies across Europe, including the NHS in the UK, AEMPS in Spain, ANSM in France and BfArM in Germany. Ads are crafted to look like official recommendations, medical advice or safety warnings from these institutions.
Generative AI allows criminals to adapt adverts to different languages, regions and demographic groups. Campaigns can be tailored in real time to match an individual’s browsing behavior, making them harder to detect and remove.
Scammers scale up and build entire fake ecosystems
Security researchers at Check Point describe how criminal groups are constructing entire ecosystems around their counterfeit medicines. These operations go beyond single adverts and encompass large volumes of AI-generated content that together create a convincing illusion of legitimacy.
Typical elements used by scammers include:
• AI-created doctors and “experts” with fabricated credentials
• digital laboratory reports and fictitious test results
• user reviews that imitate authentic testimonials
• localized “before and after” imagery tailored to specific markets
• fake storefronts designed to look like legitimate pharmacies across EU countries
Combined, these components form a cohesive narrative that can easily mislead consumers searching for medical information online.
AI-generated videos make scams harder to uncover
Synthetic videos that impersonate experts and public figures are becoming more common. Using generated audio and realistic facial movements, attackers produce clips that appear authentic even on quick inspection. Many viewers do not recognize the content as fake until it has already been shared widely.
In Sweden, a public figure recently revealed their likeness was used without consent in advertising for fake GLP-1 products. That case highlights how quickly these scams can spread, including throughout the Nordic countries.
Experts warn of eroding public trust
Experts warn that AI-fueled impersonations of health authorities create false medical credibility. This problem affects individual consumers and threatens broader trust in official health communications across Europe.
When the public encounters false messages that look official, people may become skeptical of genuine alerts and guidance from real authorities. That erosion of trust is dangerous: it can reduce compliance with important medical recommendations and undermine public health efforts.
Sweden increasingly affected
A growing number of Swedish users report seeing ads for fake GLP-1 medicines on social media platforms. These adverts often target people who recently searched for weight-loss products, and social media algorithms amplify messages that match users’ interests—making distribution highly effective.
Practical advice for consumers
Check Point recommends that consumers always:
• verify medical information via official healthcare channels;
• avoid purchasing medicines from unknown websites;
• closely examine the sender’s identity and domain names;
• be skeptical of adverts that feature familiar public figures or appear overly promotional
This trend demonstrates how AI-enabled impersonation of European health authorities is becoming a growing cyber threat across Europe. Rapid advancements in AI make it harder to distinguish fake content from legitimate governmental communications. Addressing this challenge requires coordinated efforts among authorities, online platforms and cybersecurity organizations to protect consumers from dangerous medicine-related fraud.
Key takeaways:
• Generative AI allows criminals to create highly convincing fake adverts and entire ecosystems that mimic official health authorities.
• Fake GLP-1 products are marketed as legitimate despite lacking verified ingredients or quality controls.
• AI-generated images, testimonials and videos significantly increase the credibility and spread of scams.
• Erosion of public trust in official communications is a major societal risk.
• Consumers should cross-check medical claims with recognized healthcare sources and avoid buying medicines from unverified online vendors.
Authorities, tech platforms and security researchers must collaborate to detect and remove fraudulent content, strengthen verification mechanisms and educate the public about the risks of buying medicines online. Only through joint action can the spread of dangerous, AI-enabled medical scams be contained and public confidence in health communications preserved.